Response to activated protein C decreases throughout pregnancy

Acta Obstetricia et Gynecologica Scandinavica

Volumn 81, Issue 11, 2002, Pages 1028-1032

  Benedetto, Chiara ^a   Marozio, Luca ^a   Tavella, Anna Maria ^a   Maulà, Vincenza ^a   Carmignani, Daniela ^a   Curti, Antonella ^a  

^a Department of Gynecology ^*  (Italy)

Author keywords

Activated protein C; APC resistance; Pregnancy

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5 LEIDEN;

ADULT; ANTICOAGULATION; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FETUS; GESTATIONAL AGE; HEMOSTASIS; HETEROZYGOTE; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; PARTIAL THROMBOPLASTIN TIME; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REFERENCE VALUE; STATISTICAL SIGNIFICANCE;

ACTIVATED PROTEIN C RESISTANCE; ADULT; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PROTEIN C;

EID: 0036850170     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0412.2002.811106.x     Document Type: Article

References (19)

1. Franks AL, Atrash HK, Lawson HW, Colberg KS. Obstetrical pulmonary embolism mortality. United States 1970-85. Am J Public Health 1990; 80: 720-2.
2. Department of Health, United Kingdom. Confidential Enquiries into Maternal Deaths 1994-96. London: HMSO, 1998.
3. Kjellberg U, Andersson NE, Rosén S, Tengborn L, Hellgren M. APC resistance and other haemostatic variables during pregnancy and puerperium. Thromb Haemost 1999; 81: 527-31.
4. Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C. Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-8.
5. de Visser MCH, Rosendaal FR, Bertina RM. A reduced sensitivity for activated protein C in the absence of factor V Leiden increases the risk of venous thrombosis. Blood 1999; 93: 1271-6.
6. Vasse M, Leduc O, Borg JY, Chretien MH, Monconduit M. Resistance to activated protein C. Evaluation of three functional assays. Thrombosis Res 1994; 76: 47-59.
7. Cumming AM, Tait RC, Fildes S, Yoong A, Keeney S, Hay CRM. Development to activated protein C during pregnancy. Br J Haematol 1995; 90: 725-7.
8. Mathonnet F, de Mazancourt P, Bastenaire B, Morot M, Benattar N, Beufe S et al. Activated protein C sensitivity ratio in pregnant women at delivery. Br J Haematol 1996; 92: 244-6.
9. Schlit AF, Col-De Beys C, Moriau M, Lavenne-Pardonge E. Acquired activated protein C resistance in pregnancy. Thrombosis Res 1996; 84: 203-6.
10. Peek MJ, Nelson-Piercy C, Manning RA, de Swiet M, Letsky EA. Activated protein C resistance in normal pregnancy. Br J Obstet Gynaecol 1997; 104: 1084-6.
11. Walker MC, Garner PR, Keely EJ, Rock GA, Reis MD. Changes in activated protein C resistance during normal pregnancy. Am J Obstet Gynecol 1997; 177: 162-9.
12. Clark P, Brennand J, Conkie JA, McCall F, Greer IA, Walker ID. Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb Haemost 1998; 79: 1166-70.
13. 506-Gln mutation in factor V and risk of thrombosis during pregnancy. Br J Haematol 1996; 92: 473-8.
14. Bokarewa MI, Wramsby M, Bremme K, Blomback M. Variability of the response to activated protein C during normal pregnancy. Blood Coag Fibrinol 1997; 8: 239-44.
15. Cumming AM, Tait RC, Fildes S, Hay CRM. Diagnosis of APC resistance during pregnancy. Br J Haematol 1996; 92: 1026-7.
16. Bertina RM, Reitsma PH, Rosendaal FR, Vandenbroucke JP. Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis. Thromb Haemost 1995; 74: 449-53.
17. Zoller B, Svensson PJ, He X, Dahlback B. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest 1994; 94: 2521-4.
18. Jorquera JI, Montoro JM, Fernandez MA, Aznar JA, Aznar J. Modified test for activated protein C resistance. Lancet 1994; 344: 1162-3.
19. 506) and pregnancy. Thromb Haemost 1999; 81: 532-7.